The Case CCC Hybridoma Core provides a cost-effective resource for generating, producing, and purifying monoclonal or polyclonal antibodies, as well as a repository of optimal technical capabilities and innovation regarding all aspects of antibody use. Highly specific monoclonal antibodies are an essential resource in Identifying the levels of expression, specific modifications, and tissue localization of proteins involved in all the functions that control cell growth, cell differentiation, and cell death. The Hybridoma Core continues to work on new methodology related to monoclonal antibodies. The most promising of these is an in vitro method, unique in that it takes advantage of a mouse knockout model that is expected to yield antibodies with IgG isotypes. In test experiments, spleen cells from these mice have remained highly viable in culture during antigen exposure, and have then been used successfully to perform high efficiency fusions resulting in hybridomas. Most importantly, they have confirmed that all of the hybridomas secrete antibodies with an IgG isotype, and in fact can detect no IgM production. The final steps before the Core offers this novel service will be to generate clones and determine the affinity of the resulting monoclonal. This technique should be particularly useful in developing antibodies against mouse antigens, or any antibodies that could be potentially deleterious to a mouse. It also has the potential to virtually eliminate the need for animal use in generating mouse monoclonal. Highly specific monoclonal antibodies are essential to identifying the functions and interactions of proteins involved in cell growth, cell differentiation and cell death, and therefore constitute a major contribution to cancer research. Since 2007, the Core has generated a total of 50 new monoclonal antibodies, and produced monoclonal in serum-free medium for 139 projects;approximately half of which are cancer-related. It is difficult to quantify the number of peer-reviewed publications the Core has facilitated;however, the number is certain to be an underestimate of its impact, because the usefulness of novel antibodies continues to accumulate over many years and in many different scientific areas. The Core primarily works with members from the Cell Death Regulation and Cancer Cell Signaling Programs producing antibodies to such proteins as: phospho-EI, Np65, K218me, and K221me2.

Public Health Relevance

The Case Comprehensive Cancer Center is Northeast Ohio's only NCI designated comprehensive cancer center providing bench-to-bedside medical research involving partnerships between basic, clinical and population scientists to speed translation of laboratory discoveries into new prevention/intervention and cancer treatments.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA043703-24
Application #
8765391
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
24
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Bosca, Federica; Bielecki, Peter A; Exner, Agata A et al. (2018) Porphyrin-Loaded Pluronic Nanobubbles: A New US-Activated Agent for Future Theranostic Applications. Bioconjug Chem 29:234-240
Benson, Bryan L; Li, Lucy; Myers, Jay T et al. (2018) Biomimetic post-capillary venule expansions for leukocyte adhesion studies. Sci Rep 8:9328
Morrow, James J; Bayles, Ian; Funnell, Alister P W et al. (2018) Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nat Med 24:176-185
Cooper, Gregory S; Markowitz, Sanford D; Chen, Zhengyi et al. (2018) Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing. Dig Dis Sci 63:1449-1453
Burger, Denis R; Parker, Yvonne; Guinta, Kathryn et al. (2018) PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Rynull Mice. Biol Blood Marrow Transplant 24:260-266
Anderson, Christian E; Wang, Charlie Y; Gu, Yuning et al. (2018) Regularly incremented phase encoding - MR fingerprinting (RIPE-MRF) for enhanced motion artifact suppression in preclinical cartesian MR fingerprinting. Magn Reson Med 79:2176-2182
Tartakoff, Alan Michael; Dulce, David; Landis, Elizabeth (2018) Delayed Encounter of Parental Genomes Can Lead to Aneuploidy in Saccharomyces cerevisiae. Genetics 208:139-151
Shi, Xiaojun; Wang, Bingcheng (2018) Caught in the ""Akt"": Cross-talk between EphA2 and EGFR through the Akt-PIKfyve axis maintains cellular sensitivity to EGF. Sci Signal 11:
Gromovsky, Anthony D; Schugar, Rebecca C; Brown, Amanda L et al. (2018) ?-5 Fatty Acid Desaturase FADS1 Impacts Metabolic Disease by Balancing Proinflammatory and Proresolving Lipid Mediators. Arterioscler Thromb Vasc Biol 38:218-231
Ignatz-Hoover, James J; Wang, Victoria; Mackowski, Nathan M et al. (2018) Aberrant GSK3? nuclear localization promotes AML growth and drug resistance. Blood Adv 2:2890-2903

Showing the most recent 10 out of 1227 publications